NUVISAN The Science CRO
Martin Lange is currently the Director and Head of Translational Research at Nuvisan Innovation Campus Berlin, a position Martin has held since July 2020. Prior to this role, Martin was with Bayer for nine years, where Martin also served as the Director and Head of Translational Research at the Innovation Campus Berlin. Martin 's career includes experience as a Senior Scientist and Head of Laboratory Oncology. Martin obtained their Ph.D. in Genetics from the Max Planck Institute for Molecular Genetics and holds a MSc in Biology from The Philipp University of Marburg. Additionally, Martin has worked as a Postdoctoral Fellow at the Center for Genomic Regulation and a Research Assistant at the Victor Chang Cardiac Research Institute.
This person is not in the org chart
NUVISAN The Science CRO
1 followers
Founded in Europe with more than 40 years of experience, NUVISAN is a fully integrated contract research and development, and manufacturing organization (CRO/CDMO) that offers unique, high-quality, and tailored integrated solutions along the drug discovery and development value chain. With more than 1.000 employees distributed over six locations in Germany and France including our drug discovery hub in Berlin as well as with local experts situated in Latin America, NUVISAN is pleased to offer the following portfolio of services: • Drug discovery & research - Discovery pharmacology - Discovery bioscience - Screening - Life science chemistry - Translation research - Digital life science - Toxicology - DMPK • Non-clinical studies • Pharmaceutical analysis • Topical formulation development • Chemical development with GMP manufacturing (3-10kg) • Bioanalytical labs • GMP manufacturing (up to 50Kg) • Clinical trial supplies • Phase 1 and 2 clinical studies and beyond Our services can be provided as stand-alone or integrated solutions and can be customized to your project. Email us at hello@nuvisan.com for more.